Home » FDA Approves Update for Tasigna Label
FDA Approves Update for Tasigna Label
The FDA has approved a label update for nilotinib (Tasigna). The approval includes data from a 24-month analysis of the Evaluating Nilotinib Efficacy and Safety in Clinical Trials of Newly Diagnosed Ph+ CML Patient trial.
ModernMedicine
ModernMedicine
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May